Refractory Aggressive Non-Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch Refractory Aggressive Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy (NCT04409314) | University of California, San Francisco | 2020-04-16 |
| Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial (NCT03003546) | Mayo Clinic | 2019-04-25 |
| Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03210662) | M.D. Anderson Cancer Center | 2018-02-01 |
Track Refractory Aggressive Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.